Here are what the editors at HealthDay consider to be the most important developments in Nephrology for July 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Histological Subtype Impacts Survival in Renal Cell Cancer
MONDAY, July 30 (HealthDay News) -- The histological subtype of renal cell carcinoma (RCC) impacts both overall and cancer-specific survival, according to a study published in the August issue of The Journal of Urology.
Rituximab Useful in Idiopathic Membranous Nephropathy
FRIDAY, July 27 (HealthDay News) -- For patients with idiopathic membranous nephropathy (IMN) and persistent nephrotic syndrome, rituximab treatment is associated with good rates of partial or complete remission with stabilized or improved renal function, according to a study published online July 19 in the Journal of the American Society of Nephrology.
Immunosuppressant Switch Cuts Skin Cancer Post-Transplant
WEDNESDAY, July 25 (HealthDay News) -- In kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with increased skin cancer-free survival and delayed development of new skin cancers, according to a study published in the July 26 issue of the New England Journal of Medicine.
Effect of Phosphate Binders in Chronic Kidney Disease Unclear
FRIDAY, July 20 (HealthDay News) -- Although phosphate binders lower serum and urinary phosphorus and reduce progression of secondary hyperthyroidism, they also promote progression of vascular calcification, and consequently their safety and efficacy for patients with chronic kidney disease (CKD) is unclear, according to a study published online July 19 in the Journal of the American Society of Nephrology.
Most Doctors Satisfied With Electronic Health Records
THURSDAY, July 19 (HealthDay News) -- Although only 55 percent of physicians had adopted electronic health records (EHRs) in 2011, most are somewhat or very satisfied with their system and most report enhanced patient care, according to a July data brief issued by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS).
~12,000 Preventable Deaths in English Hospitals Annually
THURSDAY, July 19 (HealthDay News) -- Approximately 12,000 hospital deaths in England each year are preventable, according to research published online July 7 in BMJ Quality & Safety.
ANCA-Associated Vasculitis Has Genetic Component
THURSDAY, July 19 (HealthDay News) -- A genome-wide association study of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis shows a genetic contribution to disease susceptibility, which differs between granulomatosis with polyangiitis and microscopic polyangiitis, according to a study published in the July 19 issue of the New England Journal of Medicine.
Poorer Patient Experience at Safety-Net Hospitals
THURSDAY, July 19 (HealthDay News) -- Safety-net hospitals (SNHs) perform worse on nearly every measure of patient experience, according to a study published online July 16 in the Archives of Internal Medicine.
Social Network Analysis IDs Informal Physician Networks
TUESDAY, July 17 (HealthDay News) -- Informal networks among physicians who share patients demonstrate substantial geographic variability, while within networks, physician and patient characteristics are similar, according to a study published in the July 18 issue of the Journal of the American Medical Association.
Hyperfiltration Independent Risk Factor for Diabetic Neuropathy
FRIDAY, July 13 (HealthDay News) -- In patients with type 2 diabetes, persistent glomerular hyperfiltration is associated with nephropathy and greater declines in renal function, according to a study published online July 6 in Diabetes Care.
New, Combined Equation More Accurately Estimates GFR
THURSDAY, July 5 (HealthDay News) -- A combined creatinine-cystatin C equation has improved performance and accuracy for estimating glomerular filtration rate (GFR), according to research published in the July 5 issue of the New England Journal of Medicine.
Factors ID'd for Outcome of Percutaneous Nephrolithotomy
TUESDAY, July 3 (HealthDay News) -- Single-tract percutaneous nephrolithotomy (sPCNL) is effective for clearing renal stones, with stone size, location, and prior shockwave lithotripsy (SWL) identified as independent predictors of stone clearance, according to a study published in the July issue of Urology.
Copyright © 2012 ScoutNews, LLC. All rights reserved.
|Previous: July 2012 Briefing - Otolaryngology||Next: July 2012 Briefing - Pathology|
Reader comments on this article are listed below. Review our comments policy.
Submit your opinion:
Are you a Doctor, Pharmacist, PA or a Nurse?
Join the Doctors Lounge online medical community